XIth International Symposium on Amyloidosis

描述(由申请人提供)： 我们已被国际淀粉样变性学会邀请主办第十三届淀粉样变性国际研讨会。研讨会将于2006年11月5-9日在马萨诸塞州的伍兹霍尔举行。自1967年在荷兰格罗宁根举行第一次会议以来，国际研讨会每隔3-5年举行一次会议，目的是分享研究数据并鼓励进行新的调查。2006年研讨会的目标是：1.集中于系统性淀粉样变性的基础和翻译研究。科学计划将包括介绍纤维形成的过程、细胞损伤和组织毒性的机制、新兴诊断和创新疗法。2.促进跨学科研究人员之间的合作，以实现促进淀粉样变性研究成果的共同目标。研讨会汇集了来自西欧和东欧、日本和美国的研究人员。这些调查人员没有机会在本次研讨会活动之外进行互动。研讨会在汇聚所有科学和医学学科的高级调查人员、初级调查人员和受训人员方面发挥了重要作用。3.鼓励学生和初级研究人员参与与淀粉样蛋白研究相关的项目。研讨会将鼓励为初级调查员和受训人员提供培训环境。他们的发言将受到鼓励。所有会议将在每次演讲后提供充足的时间进行讨论。在过去的一年里，其他会议没有讨论过研讨会的议题。已经有关于蛋白质折叠障碍的会议，但没有讨论系统性淀粉样变性本身。淀粉样变性研讨会的独特之处在于它关注对临床疾病的基本了解、新的诊断技术和转化医学的发现。这次研讨会具有很高的价值，因为它有科学家和临床医生参加，它是纳入淀粉样变性疾病临床研究的主要会议。

DESCRIPTION (provided by applicant): We have been invited to host the XIth International Symposium on Amyloidosis by the International Society of Amyloidosis. The Symposium will be held in Woods Hole Massachusetts on November 5-9, 2006. The International Symposia have met at 3-5 year intervals for the purpose of sharing research data and encouraging new investigation since the first meeting in Groningen, The Netherlands in 1967. The objectives of the 2006 symposium are to: 1. focus on basic and translational research in the systemic amyloidoses. The scientific program will include presentations on the process of fibrillogenesis, mechanisms of cell damage and tissue toxicity, emerging diagnostics, and innovative therapeutics. 2. promote collaborations among trans-disciplinary researchers towards a common goal of promoting productive research on amyloidosis. The Symposium brings together populations of investigators from Western and Eastern Europe, Japan, and the USA. These investigators do not have the opportunity to interact outside of this Symposium event. The Symposium has served a major role in bringing together senior investigators, junior investigators, and trainees of all disciplines of science and medicine. 3. encourage students and junior investigators in projects related to amyloid research. The Symposium will encourage a training environment for junior investigators and trainees. Their presentations will be encouraged. All sessions will provide ample time for discussion after each presentation. The topics of the Symposium have not been covered by other meetings in the past year. There have been meetings on protein folding disorders, but nothing addressing the systemic amyloidoses per se. The Symposium on Amyloidosis is unique in its focus on basic understanding of clinical disease, new diagnostic techniques, and translational medicine discovery. The Symposium is of great value because it is attended by both scientists and clinicians and it is the major meeting for inclusion of clinical research on amyloid diseases.